HCM · Hutchison China Ltd.

Summary

HUTCHMED (China) Limited announced the vesting of 19,913 ordinary shares under the Long Term Incentive Plan to Dr Weiguo Su, Executive Director, Chief Executive Officer and Chief Scientific Officer, on March 13, 2026, from awards granted on March 13, 2024. This disclosure complies with UK Market Abuse Regulation requirements for persons discharging managerial responsibilities.

Key takeaways

• Dr Weiguo Su received 19,913 ordinary shares (ISIN: KYG4672N1016) upon vesting of LTIP awards on 2026-03-13 at nil price.
• Awards originally granted to Dr Weiguo Su on 2024-03-13.
• Transaction occurred outside a trading venue.